WHO Names China First Emerging Market With Biological Standards Status
This article was originally published in PharmAsia News
Executive Summary
China has been chosen as the world's seventh site for a center for standardization and evaluation of biological products, the first developing nation to achieve the status given by the World Health Organization.
China has been chosen as the world's seventh site for a center for standardization and evaluation of biological products, the first developing nation to achieve the status given by the World Health Organization. The State FDA said the Institute for Biological Product Control, part of the National Institutes for Food and Drug Control, has received the status for the next four years. The designation is expected to increase China's global competitiveness in biotech research and development, a Chinese official said. (Click here for more
)
"China Gets WHO Collaborating Center For Biological Products" - Xinhua (China) (1/18/2013)